From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer
Under 50 | 50 and older | |||||||
---|---|---|---|---|---|---|---|---|
White | Black | White | Black | |||||
O/E | Excess risk | O/E | Excess risk | O/E | Excess risk | O/E | Excess risk | |
All sites | 1.55# | 38.59 | 2.30# | 76.03 | 1.07# | 11.56 | 1.30# | 42.26 |
All solid tumors | 1.59# | 37.78 | 2.37# | 72.87 | 1.10# | 14.23 | 1.34# | 42.99 |
Oral cavity and pharynx | 1.25# | 0.28 | 0.98 | −0.02 | 1.05 | 0.12 | 0.93 | −0.13 |
Digestive system | 1.04 | 0.35 | 1.08 | 0.87 | 0.97# | −1.18 | 1.10# | 3.71 |
Colon, rectum and anus | 0.91# | −0.53 | 0.98 | −0.12 | 0.97# | −0.62 | 1.07 | 1.51 |
Pancreas | 1.17# | 0.23 | 1.04 | 0.06 | 0.92# | −0.39 | 1.07 | 0.47 |
Peritoneum, omentum and mesentery | 2.11# | 0.18 | 1.96 | 0.07 | 0.92 | −0.03 | 1.06 | 0.01 |
Respiratory system | 1.23# | 1.93 | 1.69# | 5.53 | 0.95# | −1.1 | 1.08 | 1.73 |
Bones and joints | 1.93# | 0.08 | 2.04 | 0.07 | 1.1 | 0.01 | 1.22 | 0.03 |
Soft tissue including heart | 2.16# | 0.4 | 1.81 | 0.32 | 1.34# | 0.24 | 1.75# | 0.54 |
Skin excluding basal and squamous | 1.20# | 0.67 | 2.03 | 0.29 | 1.11# | 0.51 | 1.71# | 0.38 |
Breast | 2.18# | 30.16 | 3.91# | 60.98 | 1.30# | 12.67 | 1.89# | 31.31 |
Female genital system | 1.32# | 3.14 | 1.47# | 3.36 | 1.17# | 2.93 | 1.22# | 3.41 |
Corpus and uterus, NOS | 1.16# | 0.84 | 1.70# | 2.24 | 1.32# | 3.02 | 1.48# | 3.69 |
Ovary | 1.97# | 2.5 | 2.00# | 1.49 | 1.07# | 0.33 | 0.97 | -0.12 |
Urinary system | 1.13# | 0.38 | 1.14 | 0.32 | 1.02 | 0.19 | 1.23# | 1.68 |
Brain and other nervous system | 1.12 | 0.1 | 0.17# | −0.34 | 0.75# | -0.4 | 0.75 | −0.23 |
Endocrine system | 1.15# | 0.35 | 2.00# | 1.53 | 1.25# | 0.45 | 1.50# | 0.82 |
Lymphoma | 0.93 | -0.19 | 0.96 | -0.07 | 0.89# | -0.77 | 1.04 | 0.16 |
Leukemia | 1.63# | 0.84 | 3.95# | 2.65 | 1.05 | 0.23 | 1.19 | 0.58 |